It is our pleasure to invite you to the “3rd International Conference on Neuro-Oncology and Brain Tumor” going to be held during September 14-15, 2018 in Singapore. The main theme of our conference is “Innovative Techniques and Advancements in Neuro-Oncology " which covers wide range of critically important sessions.
Around 1 billion people, nearly one in six of the world’s population, suffer from Neurological disorders like Multiple Sclerosis, Alzheimer, Parkinson Disease, Stroke, Epilepsy, Migraine, Brain injuries and Neuro-infections.
The World Health Organization estimated that Neurological disorders affect up to one Billion people Worldwide. In fact, Neurological diseases make up 11% of the World’s disease burden, not including mental health and addiction disorders.
Track 1: Neuro-Oncology
The Central Nervous System is denounced to various Malevolent disorders. Central Nervous System covers its mechanism, Metastatic pestilence, Ramification, Cancers, Neurons and Sensory Receptors, Neurological Disorders, Neurodegenerative disease and Imaging agents to CNS neurofibroma. Cancer spreads to the Nervous System by direct invasion or compression from continuous tissues relates to the proximity of the Nervous System to other structures.
Global Central Nervous System Drugs market to grow at a CAGR of -3.2% over the period 2011-2015. The global central nervous system (CNS) therapeutics peddle has been forecast to reach US$133 billion by the year 2018, which increases in disease ubiquity rates due to increase in population, introduction of new drugs, and increased outgo on healthcare.
Related Conferences: Neuro-OncologyConferences | BrainTumorConferences | Neurology Conferences | Neuroscience Conferences | Neuro ConferencesClinical Oncology Conference and Radiology Conference, April 16-17, 2018 Dubai, UAE; 4th Neurological Disorders Conference and Stroke Conference, April 19-20, 2018 Dubai, UAE; 11th Oncology Research & Cancer StemCells Conference, May 10-12, 2018 Frankfurt, Germany; 3rd Neuroradiology Conference and Neuroimaging Conference, May 30-31, 2018 Osaka, Japan; Neurology Conference and Neurodisorders Conference World Congress, July 16-17, 2018 Melbourne, Australia; 2nd Neurology and Brain Disorders Conference, July 16-18, 2018 Rome, Italy; 20th Cognitive Neuroscience Conference, January 22 - 23, 2018 UAE, Dubai; Paediatric Neuro-Oncology Conference, June 29 - July 3, 2018 Denver, Colorado; Neuro-Oncology Conference, March 15-17, 2018 Brazil; American Brain Tumor Association; European Association of Neuro-Oncology; Indian Society of Neuro-Oncology; British Neuro-Oncology Society.
Track 2: Brain Tumor
Brain Tumor occurs when abnormal cells form within the brain. The symptoms of Brain stem tumors vary greatly and can include Ataxia, Cranial Nerve Palsy, headaches, problems with speech and swallowing, hearing loss, weakness, Hemiparesis, vision abnormalities, ptosis, and behavioural changes. Another possible symptom is vomiting. Any brain tumor is inherently serious and life-threatening because of its invasive and infiltrative character in the limited space of the Intracranial Cavity.
Related Conferences: Neuro-OncologyConferences | BrainTumorConferences | Neurology Conferences | Neuroscience Conferences | Neuro ConferencesClinical Oncology Conference and Radiology Conference, April 16-17, 2018 Dubai, UAE; 4th Neurological Disorders Conference and Stroke Conference, April 19-20, 2018 Dubai, UAE; 11th Oncology Research & Cancer Stem Cells Conference, May 10-12, 2018 Frankfurt, Germany; 3rd Neuroradiology Conference and Neuroimaging Conference, May 30-31, 2018 Osaka, Japan; Neurology Conference and Neurodisorders Conference World Congress, July 16-17, 2018 Melbourne, Australia; 2nd Neurology and Brain Disorders Conference, July 16-18, 2018 Rome, Italy; 20th Cognitive Neuroscience Conference, January 22 - 23, 2018 UAE, Dubai; Paediatric Neuro-Oncology Conference, June 29 - July 3, 2018 Denver, Colorado; Neuro-Oncology Conference, March 15-17, 2018 Brazil; American Brain Tumor Association; European Association of Neuro-Oncology; Indian Society of Neuro-Oncology; British Neuro-Oncology Society.
Track 3: Neoplasms
Neoplasm is an abnormal growth of tissue, which forms a mass that commonly referred to as a Tumor. Neoplasm can be caused by an Abnormal Proliferation of Tissues, that which can be caused by Genetic mutations. Not all types of Neoplasms cause a tumorous overgrowth of tissue. Malignant Neoplasms derived from epithelial cells are called Carcinomas.
Related Conferences: Neuro-OncologyConferences | BrainTumorConferences | Neurology Conferences | Neuroscience Conferences | Neuro ConferencesClinical Oncology Conference and Radiology Conference, April 16-17, 2018 Dubai, UAE; 4th Neurological Disorders Conference and Stroke Conference, April 19-20, 2018 Dubai, UAE; 11th Oncology Research & Cancer Stem Cells Conference, May 10-12, 2018 Frankfurt, Germany; 3rd Neuroradiology Conference and Neuroimaging Conference, May 30-31, 2018 Osaka, Japan; Neurology Conference and Neurodisorders Conference World Congress, July 16-17, 2018 Melbourne, Australia; 2nd Neurology and Brain Disorders Conference, July 16-18, 2018 Rome, Italy; 20th Cognitive Neuroscience Conference, January 22 - 23, 2018 UAE, Dubai; Paediatric Neuro-Oncology Conference, June 29 - July 3, 2018 Denver, Colorado; Neuro-Oncology Conference, March 15-17, 2018 Brazil; American Brain Tumor Association; European Association of Neuro-Oncology; Indian Society of Neuro-Oncology; British Neuro-Oncology Society.
Track 4: Metastatic Cancer
Metastasis is defined as the process by which Cancer cells spread to other parts of the body. Metastatic Cancer is called as Stage IV cancer among many stages of it. Metastasis is one of the hallmarks of cancer distinguishing it from benign tumors. And it can spread to distant parts of the body.
Related Conferences: Neuro-OncologyConferences | BrainTumorConferences | Neurology Conferences | Neuroscience Conferences | Neuro ConferencesClinical Oncology Conference and Radiology Conference, April 16-17, 2018 Dubai, UAE; 4th Neurological Disorders Conference and Stroke Conference, April 19-20, 2018 Dubai, UAE; 11th Oncology Research & Cancer StemCells Conference, May 10-12, 2018 Frankfurt, Germany; 3rd Neuroradiology Conference and Neuroimaging Conference, May 30-31, 2018 Osaka, Japan; Neurology Conference and Neurodisorders Conference World Congress, July 16-17, 2018 Melbourne, Australia; 2nd Neurology and Brain Disorders Conference, July 16-18, 2018 Rome, Italy; 20th Cognitive Neuroscience Conference, January 22 - 23, 2018 UAE, Dubai; Paediatric Neuro-Oncology Conference, June 29 - July 3, 2018 Denver, Colorado; Neuro-Oncology Conference, March 15-17, 2018 Brazil; American Brain Tumor Association; European Association of Neuro-Oncology; Indian Society of Neuro-Oncology; British Neuro-Oncology Society.
Track 5: Meningioma
Meningioma is referred to as slow growing Brain tumors, but their origin is not from the Brain tissue. Meningiomas are often benign tumors arising from the Arachnoidal cells of Meninges of the brain and spinal cord.
Meningiomas usually grow inward slowly, causing pressure on the Brain or Spinal cord. They interfere with the normal functions of the Brain after reaching a large size. They represent about one-third of all Primary Brain Tumors and occur most frequently in middle-aged women.
Related Conferences: Neuro-OncologyConferences | BrainTumorConferences | Neurology Conferences | Neuroscience Conferences | Neuro ConferencesClinical Oncology Conference and Radiology Conference, April 16-17, 2018 Dubai, UAE; 4th Neurological Disorders Conference and Stroke Conference, April 19-20, 2018 Dubai, UAE; 11th Oncology Research & Cancer StemCells Conference, May 10-12, 2018 Frankfurt, Germany; 3rd Neuroradiology Conference and Neuroimaging Conference, May 30-31, 2018 Osaka, Japan; Neurology Conference and Neurodisorders Conference World Congress, July 16-17, 2018 Melbourne, Australia; 2nd Neurology and Brain Disorders Conference, July 16-18, 2018 Rome, Italy; 20th Cognitive Neuroscience Conference, January 22 - 23, 2018 UAE, Dubai; Paediatric Neuro-Oncology Conference, June 29 - July 3, 2018 Denver, Colorado; Neuro-Oncology Conference, March 15-17, 2018 Brazil; American Brain Tumor Association; European Association of Neuro-Oncology; Indian Society of Neuro-Oncology; British Neuro-Oncology Society.
Track 6: Gangliocytomas
Gangliocytomas are rare indolent CNS tumours which are made up of mature neurons arising anywhere within the Neuroaxis. They differ from gangliogliomas as they lack neoplastic glial cells. Treatment involves surgical removal of the tumor. These are Neuroepithelial Tumors which line the ventricles of the brain and produces Cerebrospinal fluid.
Related Conferences: Neuro-OncologyConferences | BrainTumorConferences | Neurology Conferences | Neuroscience Conferences | Neuro ConferencesClinical Oncology Conference and Radiology Conference, April 16-17, 2018 Dubai, UAE; 4th Neurological Disorders Conference and Stroke Conference, April 19-20, 2018 Dubai, UAE; 11th Oncology Research & Cancer StemCells Conference, May 10-12, 2018 Frankfurt, Germany; 3rd Neuroradiology Conference and Neuroimaging Conference, May 30-31, 2018 Osaka, Japan; Neurology Conference and Neurodisorders Conference World Congress, July 16-17, 2018 Melbourne, Australia; 2nd Neurology and Brain Disorders Conference, July 16-18, 2018 Rome, Italy; 20th Cognitive Neuroscience Conference, January 22 - 23, 2018 UAE, Dubai; Paediatric Neuro-Oncology Conference, June 29 - July 3, 2018 Denver, Colorado; Neuro-Oncology Conference, March 15-17, 2018 Brazil; American Brain Tumor Association; European Association of Neuro-Oncology; Indian Society of Neuro-Oncology; British Neuro-Oncology Society.
Track 7: Choroid Plexus Tumor
Choroid Plexus Tumor arises from Brain tissue that invades nearby tissue and spread widely via the cerebrospinal fluid. Like other brain tumors, choroid plexus tumors are also “graded.” Like other Brain Tumors, Choroid Plexus Tumors are also “graded.” Choroid Plexus Neoplasms are rare, Intraventricular, Primary Central Nervous System (CNS) tumors derived from Choroid Plexus Epithelium that are seen predominantly in children.
Related Conferences: Neuro-OncologyConferences | BrainTumorConferences | Neurology Conferences | Neuroscience Conferences | Neuro ConferencesClinical Oncology Conference and Radiology Conference, April 16-17, 2018 Dubai, UAE; 4th Neurological Disorders Conference and Stroke Conference, April 19-20, 2018 Dubai, UAE; 11th Oncology Research & Cancer Stem Cells Conference, May 10-12, 2018 Frankfurt, Germany; 3rd Neuroradiology Conference and Neuroimaging Conference, May 30-31, 2018 Osaka, Japan; Neurology Conference and Neurodisorders Conference World Congress, July 16-17, 2018 Melbourne, Australia; 2nd Neurology and Brain Disorders Conference, July 16-18, 2018 Rome, Italy; 20th Cognitive Neuroscience Conference, January 22 - 23, 2018 UAE, Dubai; Paediatric Neuro-Oncology Conference, June 29 - July 3, 2018 Denver, Colorado; Neuro-Oncology Conference, March 15-17, 2018 Brazil; American Brain Tumor Association; European Association of Neuro-Oncology; Indian Society of Neuro-Oncology; British Neuro-Oncology Society.
Track 8: Brainstem Glioma
A Brainstem glioma is an aggressive and dangerous Cancerous Glioma Tumor in the brainstem which starts in the Brain or Spinal cord tissue and typically spread throughout the Nervous System. It is more diagnosed in children and young adults under the age of twenty. Symptoms of Brainstem glioma can develop slowly and subtly and may go unnoticed for months. A sudden onset of symptoms tends to occur with more rapidly growing, high-grade tumors. In other cases, the symptoms may arise abruptly. Unlike most Brain tumors, Brainstem Glioma is not often treated with Neurosurgery due to complications in vital parts of the Brain. Without treatment, the life expectancy is typically a few months from the time of diagnosis.
Related Conferences: Neuro-OncologyConferences | BrainTumorConferences | Neurology Conferences | Neuroscience Conferences | Neuro ConferencesClinical Oncology Conference and Radiology Conference, April 16-17, 2018 Dubai, UAE; 4th Neurological Disorders Conference and Stroke Conference, April 19-20, 2018 Dubai, UAE; 11th Oncology Research & Cancer Stem Cells Conference, May 10-12, 2018 Frankfurt, Germany; 3rd Neuroradiology Conference and Neuroimaging Conference, May 30-31, 2018 Osaka, Japan; Neurology Conference and Neurodisorders Conference World Congress, July 16-17, 2018 Melbourne, Australia; 2nd Neurology and Brain Disorders Conference, July 16-18, 2018 Rome, Italy; 20th Cognitive Neuroscience Conference, January 22 - 23, 2018 UAE, Dubai; Paediatric Neuro-Oncology Conference, June 29 - July 3, 2018 Denver, Colorado; Neuro-Oncology Conference, March 15-17, 2018 Brazil; American Brain Tumor Association; European Association of Neuro-Oncology; Indian Society of Neuro-Oncology; British Neuro-Oncology Society.
Track 9: Neuropsychology and Neuropsychiatry
The Psychosocial and Neurocognitive functioning of several cancer patients and survivors deleteriously affected by various treatments of Malignant tumors such as Chemotherapy, Radiotherapy and Hormonal therapy. Oncology researchers and Clinicians are increasingly Cognizant of the negative effects of Cancer and its treatments on the Brain and its mental processes and Cognitive outcomes.
Neuropsychology in Cancer features the current findings on the Neuropsychological effects of the Cancers and their treatments along with the most promising Neuropsychological and behavioural health interventions available to mitigate these deficits.
Related Conferences: Neuro-OncologyConferences | BrainTumorConferences | Neurology Conferences | Neuroscience Conferences | Neuro ConferencesClinical Oncology Conference and Radiology Conference, April 16-17, 2018 Dubai, UAE; 4th Neurological Disorders Conference and Stroke Conference, April 19-20, 2018 Dubai, UAE; 11th Oncology Research & Cancer Stem Cells Conference, May 10-12, 2018 Frankfurt, Germany; 3rd Neuroradiology Conference and Neuroimaging Conference, May 30-31, 2018 Osaka, Japan; Neurology Conference and Neurodisorders Conference World Congress, July 16-17, 2018 Melbourne, Australia; 2nd Neurology and Brain Disorders Conference, July 16-18, 2018 Rome, Italy; 20th Cognitive Neuroscience Conference, January 22 - 23, 2018 UAE, Dubai; Paediatric Neuro-Oncology Conference, June 29 - July 3, 2018 Denver, Colorado; Neuro-Oncology Conference, March 15-17, 2018 Brazil; American Brain Tumor Association; European Association of Neuro-Oncology; Indian Society of Neuro-Oncology; British Neuro-Oncology Society.
Track 10: Para Neoplastic Neurological Syndrome
Para Neoplastic Neurological Syndromes (PNS) are defined as the remote effects of cancer on the Nervous System. They are due to the presence of Cancer and exclusion of other known causes of the Neurological symptoms, but this criterion does not separate “true” PNS from Neurological syndromes that are coincidental with a Cancer.
Related Conferences: Neuro-OncologyConferences | BrainTumorConferences | Neurology Conferences | Neuroscience Conferences | Neuro ConferencesClinical Oncology Conference and Radiology Conference, April 16-17, 2018 Dubai, UAE; 4th Neurological Disorders Conference and Stroke Conference, April 19-20, 2018 Dubai, UAE; 11th Oncology Research & Cancer Stem Cells Conference, May 10-12, 2018 Frankfurt, Germany; 3rd Neuroradiology Conference and Neuroimaging Conference, May 30-31, 2018 Osaka, Japan; Neurology Conference and Neurodisorders Conference World Congress, July 16-17, 2018 Melbourne, Australia; 2nd Neurology and Brain Disorders Conference, July 16-18, 2018 Rome, Italy; 20th Cognitive Neuroscience Conference, January 22 - 23, 2018 UAE, Dubai; Paediatric Neuro-Oncology Conference, June 29 - July 3, 2018 Denver, Colorado; Neuro-Oncology Conference, March 15-17, 2018 Brazil; American Brain Tumor Association; European Association of Neuro-Oncology; Indian Society of Neuro-Oncology; British Neuro-Oncology Society.
Track 11: Novel Therapies in Neuro-Oncology
The Response Assessment in Neuro-Oncology (RANO) Working Group is an international, Multidisciplinary effort to develop new standardized response criteria for Clinical trials in Brain tumors. The Surgery Working Group of RANO identified surgically related End-point evaluation problems that were not addressed in the original Macdonald criteria. Macdonald criteria led to the initiation of an International effort in Neurooncology to develop Novel Response and Progression Assessment Criteria.
Related Conferences: Neuro-OncologyConferences | BrainTumorConferences | Neurology Conferences | Neuroscience Conferences | Neuro ConferencesClinical Oncology Conference and Radiology Conference, April 16-17, 2018 Dubai, UAE; 4th Neurological Disorders Conference and Stroke Conference, April 19-20, 2018 Dubai, UAE; 11th Oncology Research & Cancer Stem Cells Conference, May 10-12, 2018 Frankfurt, Germany; 3rd Neuroradiology Conference and Neuroimaging Conference, May 30-31, 2018 Osaka, Japan; Neurology Conference and Neurodisorders Conference World Congress, July 16-17, 2018 Melbourne, Australia; 2nd Neurology and Brain Disorders Conference, July 16-18, 2018 Rome, Italy; 20th Cognitive Neuroscience Conference, January 22 - 23, 2018 UAE, Dubai; paediatric Neuro-Oncology Conference, June 29 - July 3, 2018 Denver, Colorado; Neuro-Oncology Conference, March 15-17, 2018 Brazil; American Brain Tumor Association; European Association of Neuro-Oncology; Indian Society of Neuro-Oncology; British Neuro-Oncology Society.
Track 12: Advancements in Neuro-Oncology
In low-grade Gliomas, stereotactically guided conformal Radiotherapy should lead to a significant reduction in Radiation-associated late toxicity, while in selected groups of high-grade Gliomas the use of adjuvant or Neo-adjuvant Chemotherapy may improve survival. In primitive Neuroectodermal Tumours Prognostic Biological markers have been identified that are undergoing prospective evaluation. In infants the use of post-surgical chemotherapy alone may allow the postponing of Radiotherapy in selected cases. For patients with localized Medulloblastomas a new standard treatment is emerging that uses reduced-dose Craniospinal Radiotherapy followed by Platinum-based chemotherapy, while in Supratentorial primitive Neuroectodermal tumours future treatment will be aimed at improving local control.
Related Conferences: Neuro-OncologyConferences | BrainTumorConferences | Neurology Conferences | Neuroscience Conferences | Neuro ConferencesClinical Oncology Conference and Radiology Conference, April 16-17, 2018 Dubai, UAE; 4th Neurological Disorders Conference and Stroke Conference, April 19-20, 2018 Dubai, UAE; 11th Oncology Research & Cancer Stem Cells Conference, May 10-12, 2018 Frankfurt, Germany; 3rd Neuroradiology Conference and Neuroimaging Conference, May 30-31, 2018 Osaka, Japan; Neurology Conference and Neurodisorders Conference World Congress, July 16-17, 2018 Melbourne, Australia; 2nd Neurology and Brain Disorders Conference, July 16-18, 2018 Rome, Italy; 20th Cognitive Neuroscience Conference, January 22 - 23, 2018 UAE, Dubai; paediatric Neuro-Oncology Conference, June 29 - July 3, 2018 Denver, Colorado; Neuro-Oncology Conference, March 15-17, 2018 Brazil; American Brain Tumor Association; European Association of Neuro-Oncology; Indian Society of Neuro-Oncology; British Neuro-Oncology Society.
Track 13: Neurosurgical Oncology
Neurosurgery is a complex surgical method that presupposes treatment, diagnosis, and rehabilitation of disorders affecting any region of the Nervous System. Some of the preponderance common Neuro surgeries are skull base surgery, Image Guided Surgery, Laser Surgery, Spinal Neurosurgery and Neuro surgical treatment.
The Global Neurosurgery market is expected to raise 11.71% over the session of 2014-2019. Neurosurgery session includes Image Guided Surgery, Laser Surgery, Surgical operation for brain fibro adenoma, Spinal Neurosurgery, Skull base surgery, Neuro surgical treatment, Geriatric Neurosurgery, latest innovations and techniques.
Related Conferences: Neuro-OncologyConferences | BrainTumorConferences | Neurology Conferences | Neuroscience Conferences | Neuro ConferencesClinical Oncology Conference and Radiology Conference, April 16-17, 2018 Dubai, UAE; 4th Neurological Disorders Conference and Stroke Conference, April 19-20, 2018 Dubai, UAE; 11th Oncology Research & Cancer Stem Cells Conference, May 10-12, 2018 Frankfurt, Germany; 3rd Neuroradiology Conference and Neuroimaging Conference, May 30-31, 2018 Osaka, Japan; Neurology Conference and Neurodisorders Conference World Congress, July 16-17, 2018 Melbourne, Australia; 2nd Neurology and Brain Disorders Conference, July 16-18, 2018 Rome, Italy; 20th Cognitive Neuroscience Conference, January 22 - 23, 2018 UAE, Dubai; paediatric Neuro-Oncology Conference, June 29 - July 3, 2018 Denver, Colorado; Neuro-Oncology Conference, March 15-17, 2018 Brazil; American Brain Tumor Association; European Association of Neuro-Oncology; Indian Society of Neuro-Oncology; British Neuro-Oncology Society.
Track 14: Advancements in Brain Tumor
The upcoming implementation of a Neurosurgical ablation device that provides controlled therapy for brain lesions those are difficult to reach and treat. This tool, will allow us to introduce the probe into the tumor and destroy it without having to perform a Surgical Operation or Craniotomy.
Recent advances have made treatment for brain tumors much safer and more successful. Some of these newer techniques include:
•Antiseizure/Antiepileptic Drugs (AEDs)
•Steroids
•Surgery: The goal of surgery in the treatment of metastasis is to maximally remove tumor while leaving patients with good function
•Radiosurgery: A non-invasive technique that delivers numerous narrow, precisely aimed, highly focused beams of ionizing radiation that converge at a specific point.
•Radiation therapy: X-rays and other forms of radiation can destroy tumor cells or delay tumor growth.
•Chemotherapy: The use of drugs to kill rapidly dividing cells. It can be taken orally or intravenously.
•Targeted therapy: The focus on a specific element of a cell, such as molecules or pathways required for cell growth, in order to use them as a target.
Related Conferences: Neuro-OncologyConferences | BrainTumorConferences | Neurology Conferences | Neuroscience Conferences | Neuro ConferencesClinical Oncology Conference and Radiology Conference, April 16-17, 2018 Dubai, UAE; 4th Neurological Disorders Conference and Stroke Conference, April 19-20, 2018 Dubai, UAE; 11th Oncology Research & Cancer Stem Cells Conference, May 10-12, 2018 Frankfurt, Germany; 3rd Neuroradiology Conference and Neuroimaging Conference, May 30-31, 2018 Osaka, Japan; Neurology Conference and Neurodisorders Conference World Congress, July 16-17, 2018 Melbourne, Australia; 2nd Neurology and Brain Disorders Conference, July 16-18, 2018 Rome, Italy; 20th Cognitive Neuroscience Conference, January 22 - 23, 2018 UAE, Dubai; Paediatric Neuro-Oncology Conference, June 29 - July 3, 2018 Denver, Colorado; Neuro-Oncology Conference, March 15-17, 2018 Brazil; American Brain Tumor Association; European Association of Neuro-Oncology; Indian Society of Neuro-Oncology; British Neuro-Oncology Society.
Track 15: Brain Tumor Diagnosis
The following are the steps involved in Brain Tumor Diagnosis;
-
A neurological exam: A neurological exam may include, among other things, checking your vision, hearing, balance, coordination, strength and reflexes. Difficulty in one or more areas may provide clues about the part of your brain that could be affected by a brain tumor.
-
Imaging tests: Magnetic Resonance Imaging (MRI) is commonly used to help diagnose brain tumors. In some cases a dye may be injected through a vein in your arm during your MRI study.
A number of specialized MRI scan components — including functional MRI, perfusion MRI and Magnetic Resonance Spectroscopy
Other imaging tests may include Computerized Tomography (CT) scan and Positron Emission Tomography (PET).
-
Tests to find cancer in other parts of your body: If it's suspected that your Brain tumor may be a result of Cancer that has spread from another area of your body, your doctor may recommend tests and procedures to determine where the cancer originated. One example might be a CT scan of the chest to look for signs of Lung Cancer.
-
Collecting and testing a sample of abnormal tissue (biopsy): A Biopsy can be performed as part of an operation to remove the Brain tumor, or a Biopsy can be performed using a needle.
A stereotactic needle biopsy may be done for brain tumors in hard to reach areas or very sensitive areas within your brain that might be damaged by a more extensive operation. Your Neurosurgeon drills a small hole into your skull. A thin needle is then inserted through the hole. Tissue is removed using the needle, which is frequently guided by CT or MRI scanning.
The Biopsy sample is then viewed under a microscope to determine if it is cancerous or benign. This information is critical to establish a diagnosis and prognosis and, most importantly, in guiding treatment.
Track 16: Neuroradiology
Neuroradiology uses primary imaging modalities including computed tomography (CT) and magnetic resonance imaging (MRI) to focus on Endovascular or minimally invasive diagnosis and characterization of abnormalities of the Central Nervous System or head and neck lesions such as Tumors, Aneurysms, Vascular malformations, or Stroke. It involves different types of Imaging Studies like Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) for characterization of various Neurological disorders.
Related Conferences: Neuro-OncologyConferences | BrainTumorConferences | Neurology Conferences | Neuroscience Conferences | Neuro Conferences Clinical Oncology Conference and Radiology Conference, April 16-17, 2018 Dubai, UAE; 4th Neurological Disorders Conference and Stroke Conference, April 19-20, 2018 Dubai, UAE; 11th Oncology Research & Cancer Stem Cells Conference, May 10-12, 2018 Frankfurt, Germany; 3rd Neuroradiology Conference and Neuroimaging Conference, May 30-31, 2018 Osaka, Japan; Neurology Conference and Neurodisorders Conference World Congress, July 16-17, 2018 Melbourne, Australia; 2nd Neurology and Brain Disorders Conference, July 16-18, 2018 Rome, Italy; 20th Cognitive Neuroscience Conference, January 22 - 23, 2018 UAE, Dubai; Paediatric Neuro-Oncology Conference, June 29 - July 3, 2018 Denver, Colorado; Neuro-Oncology Conference, March 15-17, 2018 Brazil; American Brain Tumor Association; European Association of Neuro-Oncology; Indian Society of Neuro-Oncology; British Neuro-Oncology Society.
Track 17: Neuroimmunology
The Immunotherapy treats the Immune system in Injury and repair during wide range of Neurological disorders, Inflammatory and Autoimmune Diseases of the Nervous system such as Multiple Sclerosis (MS) and Neuromyelitis Optical (NMO) and several Brain Tumor conditions. There were numerous Radiological studies to improve Diagnosis and treatment of these diseases. The main focus is to develop the so-called Neuroprotective (nerve cell protecting) treatment approaching and establishing Modern examination procedures such as MRI (Magnetic Resonance Imaging), OCT (Optical Coherence Tomography) and Motion Analysis.
Related Conferences: Neuro-OncologyConferences | BrainTumorConferences | Neurology Conferences | Neuroscience Conferences | Neuro ConferencesClinical Oncology Conference and Radiology Conference, April 16-17, 2018 Dubai, UAE; 4th Neurological Disorders Conference and Stroke Conference, April 19-20, 2018 Dubai, UAE; 11th Oncology Research & Cancer Stem Cells Conference, May 10-12, 2018 Frankfurt, Germany; 3rd Neuroradiology Conference and Neuroimaging Conference, May 30-31, 2018 Osaka, Japan; Neurology Conference and Neurodisorders Conference World Congress, July 16-17, 2018 Melbourne, Australia; 2nd Neurology and Brain Disorders Conference, July 16-18, 2018 Rome, Italy; 20th Cognitive Neuroscience Conference, January 22 - 23, 2018 UAE, Dubai; Paediatric Neuro-Oncology Conference, June 29 - July 3, 2018 Denver, Colorado; Neuro-Oncology Conference, March 15-17, 2018 Brazil; American Brain Tumor Association; European Association of Neuro-Oncology; Indian Society of Neuro-Oncology; British Neuro-Oncology Society.
Track 18: Neuroimaging
Neuroimaging is the Mapping of human Brain using functional Magnetic Resonance Imaging (fMRI). It determines how difference and change in Cerebral structure, complexly relates to Behavior and Cognition at Multiple levels of Analysis. It includes Multimodality imaging like CT, MRI, PET, to offer most precise information noninvasively, on type of the Tumor and grade; it also guides therapeutic choices and also assesses the effects of therapy
Neuroimaging development, testing, and implementation of advanced MRI and PET Imaging biomarkers for the characterization of Brain Tumor biology and response evaluation in Clinical trials able to detect the biological behaviour of Brain Tumor more accurately.
Related Conferences: Neuro-OncologyConferences | BrainTumorConferences | Neurology Conferences | Neuroscience Conferences | Neuro ConferencesClinical Oncology Conference and Radiology Conference, April 16-17, 2018 Dubai, UAE; 4th Neurological Disorders Conference and Stroke Conference, April 19-20, 2018 Dubai, UAE; 11th Oncology Research & Cancer Stem Cells Conference, May 10-12, 2018 Frankfurt, Germany; 3rd Neuroradiology Conference and Neuroimaging Conference, May 30-31, 2018 Osaka, Japan; Neurology Conference and Neurodisorders Conference World Congress, July 16-17, 2018 Melbourne, Australia; 2nd Neurology and Brain Disorders Conference, July 16-18, 2018 Rome, Italy; 20th Cognitive Neuroscience Conference, January 22 - 23, 2018 UAE, Dubai; Paediatric Neuro-Oncology Conference, June 29 - July 3, 2018 Denver, Colorado; Neuro-Oncology Conference, March 15-17, 2018 Brazil; American Brain Tumor Association; European Association of Neuro-Oncology; Indian Society of Neuro-Oncology; British Neuro-Oncology Society.
Track 19: Medical Treatment of Metastatic Cancer to the Nervous System
A Metastatic Cancer is one which has spread from the primary site of origin into different area of the body. That occur in about one-fourth of all cancers that spread through the body. Treatment for Metastatic Cancer aims to slow the growth or spread of the Cancer. Treatment depends on the type of cancer, where it started, the size and location of the Metastasis, and other factors.
The primary tumor may be found by examining tumor tissues from the brain. Tests may include; Cerebral Angiography, Mammogram, Chest x-ray, CT scans of the Chest, Abdomen, and Pelvis to find the original tumor site, MRI of the Brain, Lumbar puncture, EEG.
Related Conferences: Neuro-Oncology Conferences | Brain Tumor Conferences | Neurology Conferences | Neuroscience Conferences | Neuro ConferencesClinical Oncology Conference and Radiology Conference, April 16-17, 2018 Dubai, UAE; 4th Neurological Disorders Conference and Stroke Conference, April 19-20, 2018 Dubai, UAE; 11th Oncology Research & Cancer Stem Cells Conference, May 10-12, 2018 Frankfurt, Germany; 3rd Neuroradiology Conference and Neuroimaging Conference, May 30-31, 2018 Osaka, Japan; Neurology Conference and Neurodisorders Conference World Congress, July 16-17, 2018 Melbourne, Australia; 2nd Neurology and Brain Disorders Conference, July 16-18, 2018 Rome, Italy; 20th Cognitive Neuroscience Conference, January 22 - 23, 2018 UAE, Dubai; Paediatric Neuro-Oncology Conference, June 29 - July 3, 2018 Denver, Colorado; Neuro-Oncology Conference, March 15-17, 2018 Brazil; American Brain Tumor Association; European Association of Neuro-Oncology; Indian Society of Neuro-Oncology; British Neuro-Oncology Society.
Track 20: Treatment of cancer related complications
Occurrence of Cancer related complications are seen during Chemotherapy because the dividing blood cells in bone marrow are also prone to damage from medications used in treatment also many of these side effects can be attributed to low blood counts. In rare cases, some Chemotherapy drugs can cause Heart damage or trigger another cancer such as Leukaemia. Some complications seen are
-
Infection
-
Fatigue
-
Bruising
-
Bleeding
-
Sleep disturbances
Preventive measures should start before cancer therapy begins, reducing the occurrence of further problems brought about by different treatment modalities.
Related Conferences: Neuro-OncologyConferences | BrainTumorConferences | Neurology Conferences | Neuroscience Conferences | Neuro ConferencesClinical Oncology Conference and Radiology Conference, April 16-17, 2018 Dubai, UAE; 4th Neurological Disorders Conference and Stroke Conference, April 19-20, 2018 Dubai, UAE; 11th Oncology Research & Cancer Stem Cells Conference, May 10-12, 2018 Frankfurt, Germany; 3rd Neuroradiology Conference and Neuroimaging Conference, May 30-31, 2018 Osaka, Japan; Neurology Conference and Neurodisorders Conference World Congress, July 16-17, 2018 Melbourne, Australia; 2nd Neurology and Brain Disorders Conference, July 16-18, 2018 Rome, Italy; 20th Cognitive Neuroscience Conference, January 22 - 23, 2018 UAE, Dubai; Paediatric Neuro-Oncology Conference, June 29 - July 3, 2018 Denver, Colorado; Neuro-Oncology Conference, March 15-17, 2018 Brazil; American Brain Tumor Association; European Association of Neuro-Oncology; Indian Society of Neuro-Oncology; British Neuro-Oncology Society.
Summary
Neuro Oncology 2018 welcomes attendees, presenters, and exhibitors from all over the world to Singapore. We are delighted to invite you all to attend and register for the “3rd International Conference on Neuro-Oncology and Brain Tumor” which is going to be held during September 14-15, 2018 in Singapore.
The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Neuro Oncology 2018, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Neuro Oncology 2018 organizing committee look forward to meeting you in Singapore.
For more details please visit - https://neurooncology.conferenceseries.com/
Importance and Scope:
Geographically market is segmented into Asia pacific, North America, Europe, Latin America and Middle East and Africa. According to market study, Market Value for Neuro-Oncology Will More than Double to $623 Million by 2020. A major part of research is going on the top Universities on Neuro Oncology across the globe. Many companies are associated with various diagnostic instruments and other therapeutics. Besides this various societies and research labs are also associated in this research field.
Increasing occurrence of malicious disorders including Meningitis and Brain Tumor disease together with other inherited CNS disorders has resulted in increased necessity for new improvements in neuroscience industry. The market is expected to experience growth over the forecast period on account of growing demand in laboratories and academic centres. The market players aim at introducing unique technologies with the ability to obtain insights to understand better the compound nervous functionalities and neural manipulations. Furthermore, increasing aggregate geriatric population every year is anticipated to drive significantly the demand owing to a growing need for better treatment and medication.
Why Singapore??
Singapore is considered as an important center for higher education and harbors, healthcare, well reputed and prestigious colleges and Universities. Singapore conferences indeed play a vital role in promoting scientific information and ideas all over the world. It can be considered as a suitable medium for the relocation of valuable knowledge about research and novel advancements worldwide. The conferences taking part here would promote a variety of scientific ideas among contenders belonging to diverse areas of science and technology.
Conference Highlights:
|
Neuro-Oncology
|
Novel Therapies in Neuro-Oncology
|
|
Brain Tumor
|
Advancements in Neuro-Oncology
|
|
Neoplasms
|
Neurosurgical Oncology
|
|
Metastatic Cancer
|
Advancements in Brain Tumor
|
|
Meningioma
|
Brain Tumor Diagnosis
|
|
Gangliocytoma
|
Neuroradiology
|
|
Choroid Plexus Tumor
|
Immunotherapy
|
|
Brainstem Glioma
|
Neuroimaging
|
|
Neuropsychology in Cancer
|
Medical Treatment of Metastatic Cancer to the Nervous System
|
|
Para Neoplastic Neurological Syndrome
|
Treatment of cancer related complications
|
Why to attend?
3rd International Conference on Neuro-Oncology and Brain Tumor is a unique forum to bring together worldwide distinguished academics in the field of Neuro-Oncology, neuroscience and neurology, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies. Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Neuro-Oncology and Brain Tumor, Neuroscience; A Unique Opportunity for Advertisers and Sponsors at this International event.
For more details please visit - https://neurooncology.conferenceseries.com/
Major Associations and Societies of Neuro Oncology Worldwide:
The global market for treatments for Neurooncology and Neuro disorders was valued at 10.5 billion in 2011 and should reach $11.1 billion in 2012. Total market value is expected to reach $16.7 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 8.5%.
There were an estimated 46.8 million people worldwide living with neurology in 2015 and this number is believed to be close to 50 million people in 2017. This number will almost double every 20 years, reaching 75 million in 2030 and 131.5 million in 2050. Much of the increase will be in developing countries. Already 58% of people with neurooncology live in low and middle income countries, but by 2050 this will rise to 68%. The fastest growth in the elderly population is taking place in China, India, and their south Asian and western Pacific neighbours.
-
Asian Society for Neuro-Oncology
-
Australian Oncology Social Work Inc
-
SNO Society for Neuro Oncology
-
American Society of Clinical Oncology
-
American Brain Tumor Association
-
American Cancer Society
-
European Scientific Society
-
Canadian Cancer Society
-
National Brain Tumor Society
-
European Scientific Society
-
Canadian Cancer Society
-
National Brain Tumor Society
The Singapore Government is supporting to develop industry-independent cancer clinical trials. The following National Cancer Cooperative Trials Groups are currently funded by Cancer in Singapore
Funds Providing Organisation
-
American Brain Tumor Association (ABTA)
-
ACT Brain Tumor
-
Ben and Catherine Ivy Foundation
-
Brain Tumor Foundation of Canada (BTFC)
-
Brain Tumor Funder's Collaborative
-
Childhood Brain Tumor Foundation
-
Concern Foundation
-
Congressionally Directed Medical Research Programs
-
Gold Hirsh Foundation
-
Grey Ribbon Crusade
-
Matthew Larson Foundation
-
National Brain Tumor Society
-
NBTS & AANS/CNS Section on Tumors
-
Pediatric Brain Tumor Foundation
-
Pediatric Oncology Grants\
-
Sontag Foundation
Key Market Players across the Globe:
-
AstraZeneca
-
Antisense Pharma
-
EMD Serono Inc
-
GlaxoSmithKline
-
Bristol-Myers Squibb
-
Pfizer Inc.
-
F. Hoffmann-La Roche Ltd Novartis AG
Target AudienceDirectors, Head of Department, Professors, Industrial Researchers, Neuro-oncologist, Radiation Oncologists, Oncologists, Neuropediatricians, Neurophysiologists, Neurosurgeons, Neurologist, Neuroradiologist, Neuro-Pathologists, Rehabilitation Specialists , Nurses, Neuroscience Researchers and Students from academia in the research of Neuro-oncology, Brain tumor organizations, Neurooncology Organisations, Neuroscience, institutions, Educational institutions, Healthcare professionals, Pharmaceutical companies and industries Business delegates.
Target Audience:
Academia: 65%
Industry: 25%
Others: 10%
A major part of research is going on the top Universities on Neuro Oncology across the globe like
-
Cern Medical Research
-
Stanford University in California
-
UC San Diego
-
University of Wolver Hampton
-
University of Chicago
-
University Hospital Heidelberg
-
University of Michigan Health System
-
Duke University in Durham, NC
-
Washington University in St. Louis, MO
-
University of California
-
Harvard Medical School
-
UCSF School of Medicine
-
Perelman School of Medicine
-
Yale School of Medicine
-
Maryland School of Medicine
-
Warren Alpert Medical School
-
University of Virginia.
-
University of Rochester Medical Centre
Major Medical Universities:
Worldwide
-
Harvard University
-
University of Minnesota
-
Mayo Medical School
-
Pittsburgh School of Medicine
-
Yale University
-
University of Cambridge
-
University of Oxford Stanford University
-
Yale University
-
Emory University
-
John Hopkins Universit
-
Kings College London
-
Feinberg School of Medicine
-
University of Wisconsin
-
UNC School of Medicine
-
Karolinska University
List of cancer drugs approved by the FDA for use in brain tumors
-
Gliolan
-
TRXE-009
-
Temozolomide
-
Afinitor (Everolimus)
-
Afinitor Disperz (Everolimus)
-
Avastin (Bevacizumab)
-
Becenum (Carmustine)
-
Bevacizumab
-
Carmubris (Carmustine)
-
Carmustine
-
Carmustine Implant
-
CeeNu (Lomustine)
-
Everolimus
-
Gliadel (Carmustine Implant)
-
Gliadel wafer (Carmustine Implant)
-
Lomustine
-
Methazolastone (Temozolomide)
-
Temodar (Temozolomide)
|
Organisation
|
Type
|
Amount
|
|
Accelerate Brain Cancer Cure
|
Grants
|
Upto $250K
|
|
AmericaBrainTumor Association (ABTA)
|
Grants
|
$75,000
|
|
Ben and Catherine Ivy Foundation
|
Grants
|
Upto $3 Million
|
|
Brain Tumor Funder's Collaborative
|
Grants
|
up to $100,000
|
|
Childhood Brain Tumor Foundation
|
Grants
|
Up to $30,000
|
|
Concern Foundation
|
Grants
|
$60,000
|
|
Goldhirsh
|
Grants
|
$600,000
|
|
Goldhirsh
|
Research Rewards
|
$100,000
|
|
Grey Ribbon Crusade
|
Grants
|
up to $70,000
|
|
Matthew Larson Foundation
|
Grants
|
up to $75,000
|
|
James S. McDonnell
|
Grants
|
$450,000
|
|
John McNicholas Glioma Scholar Award
|
Grants
|
$200,000
|
|
National Brain Tumor Society
|
Grants
|
$300,000
|
|
NBTS & AANS/CNS Section on Tumors
|
Grants
|
$75000
|
|
Pediatric Brain Tumor Foundation
|
Grants
|
$2.5 Million
|
|
Sontag Foundation
|
Grants
|
$600,000
|
2nd International Conference on Neurological Disorders and Stroke was organized during April 24-25, 2017 at JW Marriott Dubai, UAE with the support and contribution of the Organizing Committee Members.
Firstly we must thank you for trusting us and participating at Neuro Oncology 2017, a global platform to discuss various important aspects of Neurology.
There are infinite reasons to extend our gratitude to you for making the Neuro Oncology 2017 outstanding conference. We couldn't have done it without your continuous support and believe towards our organization, which mutually made to achieve Neuro Oncology 2017 a new heights in the field of Neuroscience.
The conference was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 15 countries, who have driven this event into the path of success.
The conference was organized around the theme “New Challenges and Latest Developments in Neuro Oncology and Treating Brain Tumour”. The event implanted a firm relation of upcoming strategies in the field of Novel approaches and Developments in Neurological disorders and Stroke with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.
The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following Speakers were highlighted as Keynote speakers: Sandro Iannaccone, San Raffaele hospital, Milan Italy, Joshua K. Underwood, Vermont Academy, USA, Arshad Zaman, The Leeds Teaching Hospitals, Leeds, UK, Wai Kwong Tang, Chinese University of Hong Kong and Rola Aatif Mahmood, Salmaniya Medical Complex, Bahrain.
The conference witnessed an amalgamation of peerless speakers, Keynote speakers, well-known researchers and delegates who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Neurological disorders and Stroke through their fabulous presentations at the podium of Neurpo oncology 2017.
Conference series llc LTD offers its heartfelt appreciation to all the Organizing Committee Members, Chairs and Co-chairs, Speakers, Students, Media Partners, sponsors and Editorial Board Members of Journal of Neurology, Journal of Brain Disorders & Therapy and Journal of Brain Tumors & Neurooncology who supported the conference in every aspect for the awe-inspiring exhibition at the venue.
We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members Wai Kwong Tang, Chinese University of Hong Kong Hong Kong, Cherine Fahim, CEO Neurotechsr Switzerland and Jacob Roy Kuriakose, Chairman & CEO Alzheimers Disease International India.
So as a continuation of Neuro Oncology 2017, we would like to heartily invite you to our upcoming 3rd International Conference on Neuro-Oncology and Brain Tumor during September 14-15, 2018 Singapore.
For 2018 we are expanding our focus towards all aspects of Neurological Disorders and Stroke Research findings. Our organizing committee is gearing up with more innovative and explorative sessions to unleash the boundaries of the Neurological Disorders and Stroke.
Your expertise and knowledge in the area of Neurological Disorders and Stroke will provide an opportunity to discuss and respond to a series of questions about the status of advanced Neurological Disorders and Stroke therapeutics.
Stroke is ranked as the second leading cause of death in the Dubai. In the Middle East and North Africa, stroke is emerging as a major health problem, with death rate from it will be double by 2030. In 2013 alone, U.A.E. healthcare expenditures reached an estimate $ 16.8. The healthcare market of the UAE is expected to expand at a CAGR of over 16% during 2011-2014 on back of neurological disorders. About $ 177.5 million revenue generated from medical tourism in 2012, which may rise to $ 710 million by 2020. FDA submitted drug market report on central nervous system disorders which is estimated $78 billion in 2010 and to reach nearly $81.8 billion by 2015. The market survey forecast of neurological disorders is more than $500 billion per year and also the cost of stroke care is expensive too.
We would like to organize this conference with your support to gather all the Neurological Disorders and Stroke researchers in an single platform, hope we will be honored with your support to organize Stroke 2018 in a grand level, your support will be the key of success for our next year conference.
We look forward to see your benign presence with active contribution and support to make this event successful once more.
Once again it’s our pleasure to welcome you to our upcoming
3rd International Conference on Neuro-Oncology and Brain Tumor during September 14-15, 2018 Singapore.
Lissy Ann Puno
Mitusha Verma
Sangeeta Mudaliar,
Radu Mutihac
Walter Bini
Minoo Sharbafshaaer
Satu Pihlaja
Rajib Dutta
Catherine Maurice
Suchi Deshpande
Kiran Grant
